Common Contracts

EX-10.1 2 sgmo-ex101_20150331717.htm EX-10.1 EXECUTION COPY RESEARCH, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT by and between Sangamo BioSciences, Inc. and Juvenile Diabetes Research Foundation International page

Research, Development and Commercialization Agreement • May 5th, 2020 • Delaware

• Contract Type
  Research, Development and Commercialization Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  Delaware

RESEARCH, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT by and between Sangamo BioSciences, Inc. and Juvenile Diabetes Research Foundation International

Research, Development and Commercialization Agreement • April 28th, 2015 • Sangamo Biosciences Inc • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Research, Development and Commercialization Agreement
• Filed
  April 28th, 2015
• Company
  Sangamo Biosciences Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

This Agreement (this “Agreement”) is made on this 24th day of October, 2006, by and between Sangamo BioSciences, Inc., a Delaware corporation, with its principal office at 501 Canal Boulevard, Suite A100, Richmond, CA 94804 (“Sangamo”) and Juvenile Diabetes Research Foundation International, a Pennsylvania nonprofit corporation with its principal offices at 120 Wall Street, New York, NY 10005 (“JDRF”). This Agreement shall become effective on the Effective Date (as defined below). Sangamo and JDRF are each a “Party,” and, collectively, the “Parties.”